Listar Biologie des maladies cardiovasculaires (BMC) - UMR 1034 por autor "TAVITIAN, Suzanne"
Mostrando ítems 1-4 de 4
-
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.
LUQUE PAZ, Damien; RIOU, Jeremie; VERGER, Emmanuelle ...(Blood Advances. vol. 5, n° 5, pp. 1442-1451, 2021-03-09)Article de revue -
Thrombosis with Non-Proliferative Complete Blood Count Indicative of Underlying Myeloproliferative Neoplasm, Sythrom, a Study on Behalf of the FIM Group
LE BRIS, Yannick; GALTIER, Jean; NAGUIB, Dina ...(Blood. vol. 140, n° Supplement 1, pp. 9668-9669, 2022-11-15)Article de revue -
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
AUBIN, Laura; VILAS BOAS, Rúben; DALTRO DE OLIVEIRA, Rafael ...(American Journal of Hematology, 2024-02-25)Article de revueLibre acceso